The ASCENT project in the Philippines
The Philippines is one of the five countries where the ASCENT project was implemented. 64 health care facilities in the Bulacan Province and Pampanga Province participated in the project. Participants and health care workers made use of digital adherence technologies to support people upon taking their daily TB medication at home, at work, or any venue of their choice. The first participants were enrolled in 2021. The project reached the participation of 5,470 people with TB in the Philippines.
The Philippines has a population of 107 million people and is one of the 30 high TB burden countries in the world, as listed by the World Health Organization (WHO Global Tuberculosis Report,2019). In 2018, an estimated 591,000 people suffered from TB in the Philippines, giving a TB incidence rate of 554 per 100,000 population. An estimated 18,000 people suffered from multidrug-resistant TB. The WHO estimates 27,000 people died of TB in the Philippines.
news & Stories from the Philippines
Digital adherence technology scale-up in the Philippines revs up
Philippine Business for Social Progress (PBSP) is stepping up the training of 180 programmatic management of drug-resistant tuberculosis (PMDT) nurses and regional technical staff across the Philippines.
KNCV ramps up support for the expanded use of digital adherence technology in the Philippines
PBSP will expand the use of the smart pillbox for tuberculosis (TB) treatment in the Philippines. To jumpstart the scale-up, KNCV is providing technical support to PBSP.
The smart pillbox carves a path to better tuberculosis management and cure
A first person account on how digital adherence technology can help reinforce medication adherence, in a way that benefits the patient and enhances health system efficiency.
ASCENT Philippines concludes digital adherence technology implementation activities; DAT scale-up assured in 2023
ASCENT concluded digital adherence technology (DAT) implementation activities in the Philippines. PBSP will expand DAT use nationwide.